These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8664231)

  • 1. Analysis of visual field progression in glaucoma.
    Fitzke FW; Hitchings RA; Poinoosawmy D; McNaught AI; Crabb DP
    Br J Ophthalmol; 1996 Jan; 80(1):40-8. PubMed ID: 8664231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2.
    Viswanathan AC; Fitzke FW; Hitchings RA
    Br J Ophthalmol; 1997 Dec; 81(12):1037-42. PubMed ID: 9497460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual field progression: comparison of Humphrey Statpac2 and pointwise linear regression analysis.
    McNaught AI; Crabb DP; Fitzke FW; Hitchings RA
    Graefes Arch Clin Exp Ophthalmol; 1996 Jul; 234(7):411-8. PubMed ID: 8817283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining progressive visual field loss in serial Humphrey visual fields.
    Birch MK; Wishart PK; O'Donnell NP
    Ophthalmology; 1995 Aug; 102(8):1227-34; discussion 1234-5. PubMed ID: 9097752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selecting visual field tests and assessing visual field deterioration in glaucoma.
    Nouri-Mahdavi K
    Can J Ophthalmol; 2014 Dec; 49(6):497-505. PubMed ID: 25433738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial and temporal processing of threshold data for detection of progressive glaucomatous visual field loss.
    Spry PG; Johnson CA; Bates AB; Turpin A; Chauhan BC
    Arch Ophthalmol; 2002 Feb; 120(2):173-80. PubMed ID: 11831919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oculokinetic perimetry compared with Humphrey visual field analysis in the detection of glaucomatous visual field loss.
    Wishart PK
    Eye (Lond); 1993; 7 ( Pt 1)():113-21. PubMed ID: 8325400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognizing glaucomatous field loss with the Humphrey STATPAC.
    Enger C; Sommer A
    Arch Ophthalmol; 1987 Oct; 105(10):1355-7. PubMed ID: 3662906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the prediction of visual field progression in glaucoma using spatial processing.
    Crabb DP; Fitzke FW; McNaught AI; Edgar DF; Hitchings RA
    Ophthalmology; 1997 Mar; 104(3):517-24. PubMed ID: 9082283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perimetric probability maps to separate change caused by glaucoma from that caused by cataract.
    Bengtsson B; Lindgren A; Heijl A; Lindgren G; Asman P; Patella M
    Acta Ophthalmol Scand; 1997 Apr; 75(2):184-8. PubMed ID: 9197570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-assisted interpretation of visual fields in glaucoma.
    Asman P
    Acta Ophthalmol Suppl (1985); 1992; (206):1-47. PubMed ID: 1467748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency doubling technology perimetry for detection of visual field progression in glaucoma: a pointwise linear regression analysis.
    Liu S; Yu M; Weinreb RN; Lai G; Lam DS; Leung CK
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2862-9. PubMed ID: 24595388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis.
    Wang M; Shen LQ; Pasquale LR; Petrakos P; Formica S; Boland MV; Wellik SR; De Moraes CG; Myers JS; Saeedi O; Wang H; Baniasadi N; Li D; Tichelaar J; Bex PJ; Elze T
    Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):365-375. PubMed ID: 30682206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The groningen longitudinal glaucoma study III. The predictive value of frequency-doubling perimetry and GDx nerve fibre analyser test results for the development of glaucomatous visual field loss.
    Heeg GP; Jansonius NM
    Eye (Lond); 2009 Aug; 23(8):1647-52. PubMed ID: 19011607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency-doubling technology perimetry for detection of the development of visual field defects in glaucoma suspect eyes: a prospective study.
    Liu S; Yu M; Weinreb RN; Lai G; Lam DS; Leung CK
    JAMA Ophthalmol; 2014 Jan; 132(1):77-83. PubMed ID: 24177945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated visual fields: a new approach to measuring the binocular field of view and visual disability.
    Crabb DP; Viswanathan AC
    Graefes Arch Clin Exp Ophthalmol; 2005 Mar; 243(3):210-6. PubMed ID: 15806374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of current technology used in evaluating visual function in glaucoma.
    Turalba AV; Grosskreutz C
    Semin Ophthalmol; 2010; 25(5-6):309-16. PubMed ID: 21091017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Novel Visual Field Analyzer Application for Automated Classification of Glaucoma Severity.
    Germano RAS; de Moraes CG; Susanna R; Dantas DO; Neto EDS
    J Glaucoma; 2017 Jun; 26(6):586-591. PubMed ID: 28368999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual field progression with frequency-doubling matrix perimetry and standard automated perimetry in patients with glaucoma and in healthy controls.
    Redmond T; O'Leary N; Hutchison DM; Nicolela MT; Artes PH; Chauhan BC
    JAMA Ophthalmol; 2013 Dec; 131(12):1565-72. PubMed ID: 24177807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pointwise univariate linear regression of perimetric sensitivity against follow-up time in glaucoma.
    Wild JM; Hutchings N; Hussey MK; Flanagan JG; Trope GE
    Ophthalmology; 1997 May; 104(5):808-15. PubMed ID: 9160027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.